Ending months of silence, Cellular Dynamics International Inc. is finally talking about its nearly $41 million fund-raise that it says makes it the highest-funded player in the stem cells industry. The company will use the $40.6 million infusion of capital to boost production of its stem-cell derived beating heart cells, the company’s first commercial product, […]
Highlights of the important and the interesting from the world of healthcare: Democrats again take aim at insurance premium hikes: Legislation that would give federal regulators the power to veto insurance premium rate hikes is back on the table. The idea was floated back in February and embraced by President Obama when he was heating […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Another day, another dollar -- or rather a few million dollars -- for pluripotent stem cell company Cellular Dynamics Inc. After filing a regulatory document last week with the Securities and Exchange Commission stating it had raised $31 million, the Wisconsin company amended the filing. The company now has raised $40.6 million in equity, according to a new document.
Stem cell company Cellular Dynamics International Inc. has received a staggering $31 million investment, according to a filing with the Securities and Exchange Commission. The company specializes in pluripotent stem cells, which can differentiate into any cell type for use in drug development.